Innovation, the gene and development origin of Talsy,
driving us to make breakthroughs to make life shine
中文
English
Founded in 1994 and headquartered in Tianjin, Tasly Group has grown from its origins as Tasly Pharmaceutical Group Co., Ltd.—a leading modern Chinese medicine enterprise—into a global high-tech conglomerate. Guided by an international vision and driven by the health industry, Tasly focuses on digital health products and smart healthcare services. As a pioneer and innovator in China’s health sector, Tasly adheres to the philosophy of “Goodness for All, Intelligence for the Future,” striving to build a global life and health value ecosystem based on symbiosis and shared growth.
Today, Tasly’s business spans both wellness & lifestyle products and healthcare services, with operations across Tianjin, Guizhou, Hebei, Yunnan, Jilin, Shaanxi, Hong Kong, Japan, and Australia. The company has received four National Science and Technology Progress Awards and multiple recognitions such as “National Intelligent Manufacturing Demonstration Factory.”
Wellness & Lifestyle Products
Guotai Digital Liquor Group (Guizhou Province): Recognized as the second-largest liquor producer in Maotai Town, Guotai operates five modern production bases with an annual output of 56,000 tons of authentic Daqu Maotai-flavor liquor. Leveraging six generations of technological upgrades, it has built an internationally leading intelligent brewing system that replicates traditional craftsmanship with consistency and quality. It has been awarded “National Green Factory”and“Intelligent Manufacturing Demonstration Factory,” with tax-inclusive sales exceeding RMB 10 billion in 2021 and brand value surpassing RMB 200 billion in 2024.
Depure Digital Tea (Yunnan Province): Focused on Pu’er tea, the company has built one of the world’s largest fermentation and R&D bases. Through patented bioprocessing and digital extraction, it delivers safe, convenient, and health-oriented tea granule products with international organic certifications. The portfolio continues to expand into ready-to-drink teas and tea-based functional foods.
C-Cell Vitality Natural Mineral Water(Jilin Province): Drawn from underground springs in Changbai Mountain, this product features patented small-molecule clustering technology, pH 8.5 mild alkalinity, and over 20 minerals and trace elements. Research has validated benefits such as alcohol metabolism and uric acid reduction, distinguishing it in the premium water market.
Tasly integrates online and offline channels, building an open innovation platform that connects with global partners in supply chain management, livestream commerce, and content marketing to better meet diverse consumer demands.
Healthcare Services
Nutraceuticals and Functional Foods: With 30 years of expertise in chronic disease prevention and management, Tasly develops innovative health products targeting cardiovascular health, immunity, liver protection, probiotics, and ginseng-based supplements. Market-recognized products include Zhuoqing Instant Tea, Ginkgo Biloba Dropping Pills, and Probiotic Powders.
Cell & Gene Therapy (CGT): Leveraging mesenchymal stromal cells (MSCs) and immune cell platforms, Tasly is building a leading CGT ecosystem. In China, it vertically integrates the full industry chain and expands across multiple therapeutic areas with commercialization priority. Internationally, it has established cell preparation centers in Japan and Australia, working closely with local clinics to accelerate the clinical adoption of stem cell therapies.
Digital TCM: In response to the AI revolution, Tasly launched “Digital Materia Medica,” the world’s first AI model for traditional Chinese medicine R&D. The platform enhances efficiency in drug discovery and clinical decision-making while supporting preventive healthcare systems.
Synthetic Biology: Tasly is advancing industrial applications of high-activity enzymatic decomposition technology, transforming agricultural by-products such as sorghum stalks and distillers’ grains into high-value compounds. This innovation aligns sustainable agriculture with the green transformation of the liquor industry.
Social Responsibility
Tasly integrates social responsibility into its core development strategy, pioneering the concept of “industrial common good.” It has played an active role in poverty alleviation and rural revitalization, earning recognition such as National Advanced Private Enterprise for Targeted Poverty Alleviation. Through the Tasly Charity Foundation, it has received national awards for philanthropy and corporate social responsibility.
Looking Ahead
With a strategy rooted in innovation and digital empowerment, Tasly continues to embrace internationalization and actively participates in the development of the “Belt and Road” regions. The company is committed to becoming a global leader in life and health, meeting the diverse needs of people worldwide and delivering long-term social value.
Innovation, running through the whole process of our establishment, development, transformation and upgrading, is the gene of Tasly and the origin of power to constantly drive us to break barriers, coruscating strong vitality and meeting future challenges.
Layout of the world's leading stem cell industry chain
Integration of Chinese and Western medicine innovation
Tianshili Pharmaceutical Company was established
Compound Danshen Dripping Pill was approved by the National New Drug Certificate
Compound Danshen Dripping Pill was approved by FDA IND
Built Guotai Liquor Company after acquisition of a time-honored brewing enterprise in Moutai Town
Tasly (600535) was listed in Shanghai Stock Exchange
Tasly Pharma. (US) was established
Compound Danshen Dripping Pill passed FDAⅡ clinical trial
Tasly Huai 'an Biomedical Industrial Park started construction
The results of "Recombinant Human Prourokinase for Injection", a national classⅠ bio-thrombolytic drug, were released
Guotai Winery was established in Renhuai Famous Wine Industrial Park
Tasly Deepure Biological Tea Valley was completed
Jilin Tasly Mineral Water Co.,Ltd launched into production.
State-local JoinEngineering Laboratory and State Key Laboratory of Core Technology in Innovative Chinese Medicine were approved
Compound Danshen Dripping Pill passed FDAⅢ clinical trial
Signed T89 R&D and marketing cooperation with Arbor Company in the United States
Be the first to complete the layout of the whole stem cell industry chain in China
The clinical phaseⅡtrial of Compound Danshen Dripping Pill on prevention and treatment of acute altitude syndrome was completed
Set up an International TCM Sharing Platform and carry out international academic exchanges on jointly fight of COVID-19
Tasly Holding Group awarded as National Advanced Collective in Poverty Alleviation
Tasly Great Health Industry Investment Group listed in Top 500 Chinese Manufacturing Enterprises in 2021
Tasly Great Health Industry Investment Group listed in Top 500 Private Enterprises in China in 2021
Tasili Pharmaceutical Group won the honorary title of National Youth Civilization
Tasly Pharma. Group was listed in the "Top100 List of Chinese Traditional Medicine Enterprises in 2019"
Tasly Pharma. Group was listed in Top 100 in Science and Technology Innovation
Tasly Holding Group was listed in China's Top 500 Manufacturers in 2020
Tasly Holding Group won the Annual Poverty Alleviation Award of 15th People's Corporate Social Responsibility Award
Tasly Holding Group won the title of "Backbone Enterprise of Pharmaceutical Industry in 70 Years since the Founding of New China"
Tasly Pharma. Group was selected as one of the Top 100 Innovative Pharmaceutical Enterprises in China
Tasly Holding Group was listed in the "2019 Top 500 Chinese Private Enterprises" ranking 290th and “2019 China's Top 500 Private Enterprises in Manufacturing" ranking 168th
Tasly Holding Group won the "National Public Welfare Contribution Award"Tasly Holding Group was honored as "China's Industrial Model Enterprise"
Tasly Holding Group was awarded the "Advanced Private Enterprise targeted Poverty
Alleviation" of "Ten thousand Enterprises helping Ten Thousand Villages"
Tasly pharmaceutical group entered "TOP5 of China TCM r&d strength list 2018"
Tasly Holding Group was listed in the "2018 China's Top 500 Manufacturing Enterprises", ranking 259th
Tasly Holding Group won the "Originality quality brand" award
Shanghai Tasly Pharmaceutical Co., LTD. "Recombinant Human Urokinase for Injection" was awarded "The Most Innovative Drug with Clinical Value"
Tasly Holding Group won the award of "Top 10 Industrial Tourism Brand"
Tasly was listed as one of the Top 100 Chinese Brands in 2017
Tasly Compound Danshen Dripping Pill’s brand value exceeding 5 billion RMB, ranked in "2016 Chinese Drug Brand Value List"
Tasly (600535) ranked in the "2017 China Listed Company Brand Value List (Top50 Private Enterprises)"Tasly Pharmaceutical Group was awarded the title of "Intelligent Manufacturing Pilot Demonstration" by the Ministry of Industry and Information Technology
Tasly (600535) was awarded the title of "Top 100 Listed Companies by Value in China's main board"
Tasly Holding Group ranks No. 264 in "2016 China's Top 500 Manufacturers List"
Tasly Pharmaceutical Group was selected as one of the Top 20 Most Competitive Listed Pharmaceutical Companies in China.